Cargando…

Acute effects of acrolein in human volunteers during controlled exposure

Context: Acrolein is a reactive aldehyde mainly formed by combustion. The critical effect is considered to be irritation of the eyes and airways; however, the scarce data available make it difficult to assess effect levels. Objective: The aim of the study was to determine thresholds for acute irrita...

Descripción completa

Detalles Bibliográficos
Autores principales: Dwivedi, Aishwarya M., Johanson, Gunnar, Lorentzen, Johnny C., Palmberg, Lena, Sjögren, Bengt, Ernstgård, Lena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4732413/
https://www.ncbi.nlm.nih.gov/pubmed/26635308
http://dx.doi.org/10.3109/08958378.2015.1115567
_version_ 1782412698381713408
author Dwivedi, Aishwarya M.
Johanson, Gunnar
Lorentzen, Johnny C.
Palmberg, Lena
Sjögren, Bengt
Ernstgård, Lena
author_facet Dwivedi, Aishwarya M.
Johanson, Gunnar
Lorentzen, Johnny C.
Palmberg, Lena
Sjögren, Bengt
Ernstgård, Lena
author_sort Dwivedi, Aishwarya M.
collection PubMed
description Context: Acrolein is a reactive aldehyde mainly formed by combustion. The critical effect is considered to be irritation of the eyes and airways; however, the scarce data available make it difficult to assess effect levels. Objective: The aim of the study was to determine thresholds for acute irritation for acrolein. Methods: Nine healthy volunteers of each sex were exposed at six occasions for 2 h at rest to: clean air, 15 ppm ethyl acetate (EA), and 0.05 ppm and 0.1 ppm acrolein with and without EA (15 ppm) to mask the potential influence of odor. Symptoms related to irritation and central nervous system effects were rated on 100-mm Visual Analogue Scales. Results: The ratings of eye irritation were slightly but significantly increased during exposure to acrolein in a dose-dependent manner (p < 0.001, Friedman test) with a median rating of 8 mm (corresponding to “hardly at all”) at the 0.1 ppm condition and with no influence from EA. No significant exposure-related effects were found for pulmonary function, or nasal swelling, nor for markers of inflammation and coagulation in blood (IL-6, C-reactive protein, serum amyloid A, fibrinogen, factor VIII, von Willebrand factor, and Clara cell protein) or induced sputum (cell count, differential cell count, IL-6 and IL-8). Blink frequency recorded by electromyography was increased during exposure to 0.1 ppm acrolein alone but not during any of the other five exposure conditions. Conclusion: Based on subjective ratings, the present study showed minor eye irritation by exposure to 0.1 ppm acrolein.
format Online
Article
Text
id pubmed-4732413
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-47324132016-02-16 Acute effects of acrolein in human volunteers during controlled exposure Dwivedi, Aishwarya M. Johanson, Gunnar Lorentzen, Johnny C. Palmberg, Lena Sjögren, Bengt Ernstgård, Lena Inhal Toxicol Research Article Context: Acrolein is a reactive aldehyde mainly formed by combustion. The critical effect is considered to be irritation of the eyes and airways; however, the scarce data available make it difficult to assess effect levels. Objective: The aim of the study was to determine thresholds for acute irritation for acrolein. Methods: Nine healthy volunteers of each sex were exposed at six occasions for 2 h at rest to: clean air, 15 ppm ethyl acetate (EA), and 0.05 ppm and 0.1 ppm acrolein with and without EA (15 ppm) to mask the potential influence of odor. Symptoms related to irritation and central nervous system effects were rated on 100-mm Visual Analogue Scales. Results: The ratings of eye irritation were slightly but significantly increased during exposure to acrolein in a dose-dependent manner (p < 0.001, Friedman test) with a median rating of 8 mm (corresponding to “hardly at all”) at the 0.1 ppm condition and with no influence from EA. No significant exposure-related effects were found for pulmonary function, or nasal swelling, nor for markers of inflammation and coagulation in blood (IL-6, C-reactive protein, serum amyloid A, fibrinogen, factor VIII, von Willebrand factor, and Clara cell protein) or induced sputum (cell count, differential cell count, IL-6 and IL-8). Blink frequency recorded by electromyography was increased during exposure to 0.1 ppm acrolein alone but not during any of the other five exposure conditions. Conclusion: Based on subjective ratings, the present study showed minor eye irritation by exposure to 0.1 ppm acrolein. Taylor & Francis 2015-12-06 2015-12-04 /pmc/articles/PMC4732413/ /pubmed/26635308 http://dx.doi.org/10.3109/08958378.2015.1115567 Text en © 2015 The Author(s). Published by Taylor & Francis. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
spellingShingle Research Article
Dwivedi, Aishwarya M.
Johanson, Gunnar
Lorentzen, Johnny C.
Palmberg, Lena
Sjögren, Bengt
Ernstgård, Lena
Acute effects of acrolein in human volunteers during controlled exposure
title Acute effects of acrolein in human volunteers during controlled exposure
title_full Acute effects of acrolein in human volunteers during controlled exposure
title_fullStr Acute effects of acrolein in human volunteers during controlled exposure
title_full_unstemmed Acute effects of acrolein in human volunteers during controlled exposure
title_short Acute effects of acrolein in human volunteers during controlled exposure
title_sort acute effects of acrolein in human volunteers during controlled exposure
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4732413/
https://www.ncbi.nlm.nih.gov/pubmed/26635308
http://dx.doi.org/10.3109/08958378.2015.1115567
work_keys_str_mv AT dwivediaishwaryam acuteeffectsofacroleininhumanvolunteersduringcontrolledexposure
AT johansongunnar acuteeffectsofacroleininhumanvolunteersduringcontrolledexposure
AT lorentzenjohnnyc acuteeffectsofacroleininhumanvolunteersduringcontrolledexposure
AT palmberglena acuteeffectsofacroleininhumanvolunteersduringcontrolledexposure
AT sjogrenbengt acuteeffectsofacroleininhumanvolunteersduringcontrolledexposure
AT ernstgardlena acuteeffectsofacroleininhumanvolunteersduringcontrolledexposure